Navigation Links
Gastric Banding Reverses Impact of Type 2 Diabetes
Date:1/22/2008

MELBOURNE, Australia, Jan. 22 /PRNewswire/ -- A new world-first study by Monash University researchers has found gastric banding surgery has a profound impact on one of society's biggest health issues -- diabetes.

The study, published today in Journal of the American Medical Association (JAMA), found obese patients with Type 2 diabetes who underwent gastric banding were five times more likely to have their diabetes go into long term remission, compared with patients who engaged in conventional weight loss therapies, such as a controlled calorie diet and exercise.

The four-year study, which was led by Drs John Dixon and Paul O'Brien from Monash University's Centre for Obesity Research and Education (CORE), monitored 60 volunteers for two years who underwent significant weight loss of more than 10 per cent of their body weight.

Dr Dixon said of those who underwent gastric banding surgery, 73 per cent achieved remission for Type 2 diabetes, compared to just 13 percent of the people who underwent conventional therapy.

"Our study presents strong evidence that obese patients with a Body Mass Index greater than 30 with Type 2 diabetes need to lose a significant amount of weight to improve their overall health and glycemic management," Dr Dixon said.

"Our study shows that gastric banding surgery can assist those patients to achieve this -- and with sustained results.

Professor O'Brien said obesity and Type 2 diabetes were strongly linked and combine to present one of the greatest public health problems facing our community.

"We found that the amount of weight loss was a key determinant of effectiveness. Most of those losing ten per cent of their total weight had remission of the diabetes. Few who lost less did so."

Dr Dixon said the study also found patients who lost substantial weight could not only dramatically reduce their diabetes medications, but also those for controlling blood pressure and lowering blood fats.

"We found that after two years, the surgical group when compared to the conventional therapy group displayed a four times greater reduction in glycated haemoglobin, which can be an indicator of poorly controlled diabetes," Dr Dixon said.

Gastric banding is a medical procedure where a band is placed around a patient's stomach to reduce appetite and food intake. For more information on the study, visit the CORE website: http://www.core.monash.org/


'/>"/>
SOURCE Monash University
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Endoscopy Identified as Safe and Effective Method in Treating Common Complication of Gastric Bypass Surgery
2. Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health
3. Hopkins Report: Focusing on Family Planning Lessens HIV Impact
4. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
5. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
6. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
7. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
8. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
9. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
10. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
11. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... -- Eli Lilly and Company (NYSE: LLY ) ... updated financial guidance for 2016 on Thursday, December 15, ... that day with the investment community and media to ... conference call will begin at 10 a.m. ET. Investors, ... webcast of the conference call through a link that ...
(Date:12/2/2016)... , December 2, 2016 Orthopedic ... & Support) is Expected to Gain a Significant Market Share ... Orthopedic Ailments  ... , According to a ... on Medical Implants Sterile Packaging: Clamshell Product Type Segment Projected ...
(Date:12/2/2016)... Research and Markets has announced the addition of ... Markets and Companies" to their offering. ... , , ... The market value of drug delivery technologies and the anticancer drugs ... according to organs involved and the types of cancer as well ...
Breaking Medicine Technology:
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... ... ... With the number of pain management programs available for people suffering with ... that works for them. When an inventor from Suisun City, Calif., was unsuccessful in ... share it with others. , He developed a prototype for PRO GO MASSAGE to ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. Raffi ... be included in the 2016 “Guide to America’s Top Plastic Surgeons” for seven ... amalgamation of their education, experience, and professional associations. , One the most ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is proud to announce ... covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping patients ... life 6 years in the last 3 decades,” says Dr. Valentine Fuster, a ...
(Date:12/2/2016)... Honolulu, Hawaii (PRWEB) , ... December 02, 2016 ... ... 3, 2016 at the Hyatt Regency Waikiki Beach Resort and Spa in Honolulu, ... (CME) in the field of pain management. , The demand for supplemental ...
Breaking Medicine News(10 mins):